Skip to main content

Table 5 Multivariate analysis of PFS and OS in patients with advanced tumors treated with ICI

From: Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study

PFS/OS

B

SE

Wald

df

Sig

Exp(B)

95% CI for Exp(B)

Lower

Upper

PFS

 SIRI

0.265

0.108

6.029

1

0.014

1.304

1.055

1.611

 PNI

 − 0.260

0.111

5.462

1

0.019

0.771

0.620

0.959

OS

 PAB

 − 0.517

0.158

10.709

1

0.001

0.596

0.437

0.813

 PNI

 − 0.419

0.157

7.119

1

0.008

0.657

0.483

0.895

  1. PFS Progression-free survival, OS Overall survival, CI Confidence interval, SIRI Systemic inflammatory response index, PNI Prognostic nutritional index, PAB Prealbumin, ALB Albumin
  2. P < 0.05 is statistically significant
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us